98%
921
2 minutes
20
Objective: To compare the pregnancy outcomes of embryo transfer (ET) and frozen-thawed embryo transfer (FET) after controlling for maternal confounding factors.
Study Design: Descriptive analytical study. Place and Duration of the Study: Reproductive Medicine Centre, Children's Hospital of Shanxi and Women Health Centre of Shanxi, Affiliated Hospital of Shanxi Medical University, Taiyuan, China, from January 2015 to September 2022.
Methodology: Clinical data and pregnancy outcomes of 1,051 sperm-donor in-vitro fertilisation IVF/ICSI embryo-transfer cycles, divided into initial FET and fresh ET groups, were compared. Primary outcomes included clinical pregnancy rate, miscarriage rate, and live birth rate.
Results: Significant differences were observed in clinical pregnancy and live birth rates (44.02% vs. 53.63%, p = 0.018; 34.78% vs. 44.87%, p = 0.012) but not in miscarriage or ectopic pregnancy rates (18.52% vs. 14.41%, p = 0.339; 2.47% vs. 1.94%, p = 0.752) between the groups.
Conclusion: In 1,065 sperm-donor IVF cycles, frozen-thawed embryos yielded higher clinical pregnancy and live birth rates, particularly with single ET. FET is a successful, safe, and preferable option for couples using donor sperm in assisted reproductive technologies.
Key Words: Donor sperm, Fresh embryo transfer, Frozen-thawed embryo transfer, Pregnancy outcome, Assisted reproductive technique.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.29271/jcpsp.2025.06.703 | DOI Listing |
Front Endocrinol (Lausanne)
September 2025
State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University, Third Hospital, Beijing, China.
Objective: This study explores the metabolic profiles in the peripheral blood of infertile patients with adenomyosis (ADM) to identify key metabolites affecting pregnancy outcomes in these patients undergoing frozen embryo transfer (FET). Our goal is to create a metabolite-based clinical prediction model for pregnancy outcomes in adenomyosis-associated infertility.
Methods: This prospective cohort study from the Reproductive Center at Peking University Third Hospital enrolled 94 infertile patients with adenomyosis and control (CTRL) patients undergoing FET.
J Assist Reprod Genet
September 2025
Bahçeci Fulya IVF Center, Infertility Clinic, Istanbul, Turkey.
Purpose: To assess the intra-individual variability of serum progesterone (P) levels on embryo transfer (ET) day, when the same dose of intramuscular progesterone (IM-P) was used in two consecutive hormone replacement therapy (HRT) frozen embryo transfer (FET) cycles.
Methods: A total of 75 patients undergoing two consecutive HRT-FET cycles in one year performed at Bahceci Ankara IVF Center between November 2019 and February 2022 were retrospectively analyzed. Serum P levels were measured at the 117th-119th hours of support by a single laboratory.
Anim Reprod Sci
September 2025
Department of Biomedical & Clinical Sciences (BKV), BKH/Obstetrics & Gynecology, Faculty of Medicine and Health Sciences, Linköping University, Linköping SE-58185, Sweden.
Embryo transfer (ET) is a valuable reproductive technology in pigs, albeit its efficiency remains significantly lower than that of natural mating or artificial insemination (AI), owing to high embryonic death rates. Critical for embryo survival and pregnancy success is the placenta, which supports conceptus development through nutrient exchange, hormone production, and immune modulation. Alterations in placental development and function may therefore underlie the reduced efficiency of ET.
View Article and Find Full Text PDFEquine Vet J
September 2025
Sharjah Equine Hospital, Sharjah, UAE.
Background: Vitrified embryos ≤300 μm give better pregnancy rates following warming and transfer than larger ones. Embryo recovery undertaken close to when the embryo enters the uterus (Day 6-6.5) helps in the recovery of embryos ≤300 μm.
View Article and Find Full Text PDFPLoS One
September 2025
Division of Reproductive Engineering, Center for Animal Resources and Development, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan.
Zygotes are used to create genetically modified animals by electroporation using the CRISPR-Cas9 system. Such zygotes in rats are obtained from superovulated female rats after mating. Recently, we reported that in vivo-fertilized zygotes had higher cryotolerance and developmental ability than in vitro-fertilized zygotes in Sprague Dawley (SD) and Fischer 344 rats.
View Article and Find Full Text PDF